A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Transformation & Innovation Market Intelligence Service.
UNICEF delivers 254,000 Pfizer COVID-19 vaccine doses to Ukraine with support from GAVI; COVID-19, SARS and influenza have affected over 3.7 million Ukrainians since October 2023
Published:
March 28, 2024
by Interfax Ukraine Political News
|
Moderna announces Phase 3 success of next-gen COVID-19 vaccine, forthcoming flu combo vaccine, and progress in pivotal viral caccines set for 2024
Published:
March 28, 2024
by Industry Intelligence Inc.
|
Moderna reports early progress in vaccines for Epstein-Barr virus, norovirus and shingles during its vaccines day; Moderna reports vaccine candidates show stronger immune responses and generally well-tolerated results in early clinical trials
Published:
March 27, 2024
by FierceBiotech
|
Moderna initiates final phase of trials for four vaccines against latent infections, including chickenpox and shingles, and norovirus responsible for gastroenteritis; the company also developing a new-generation COVID-19 vaccine
Published:
March 27, 2024
by CE Noticias Financieras (Latin America)
|
FDA approves Roche's cobas Malaria test for use on the cobas 6800/8800 Systems, making it the first molecular test for malaria screening in US; malaria affected about 292 million people in 2022, with Africa accounting for 94% of cases
Published:
March 26, 2024
by GlobeNewswire Europe
|
Ask us about our Transformation & Innovation market view